AME Publishing Company

AME Publishing Company is an academic publishing company established in July 2009 and headquartered in Hong Kong. Its publishing program focuses on medical and healthcare scholarship, combining periodical publishing with books and electronic publications. The company operates from Hong Kong and has maintained additional offices in Guangzhou, Changsha, Nanjing, Shanghai, Chengdu, Beijing, Taipei, and Hangzhou, giving it a substantial operational presence across major Chinese publishing and research centers. AME's principal business is the publication of medical journals. Reference material describes a portfolio of more than 50 medical journals and, in a later description, more than 60 medical journals. These publications cover areas of clinical medicine, biomedical research, surgery, oncology, and related healthcare disciplines, although the available reference material does not provide a complete journal-by-journal catalogue. In addition to journals, AME has published English-language and Chinese-language medical books, together with electronic books. The cited publishing output includes more than 20 English-language books, 28 Chinese-language books, and 60 e-books. The name AME has been explained as standing for phrases including “Academic Made Easy,” “Academic Made Excellent,” or “Academic Made Enthusiastic.” These interpretations express the company’s stated orientation toward making academic communication and dissemination more accessible, effective, and engaging. Its role is therefore broader than that of a conventional trade publisher: it serves researchers, clinicians, medical institutions, professional societies, and readers seeking specialized medical information. AME has also attracted scrutiny in discussions about scholarly publishing standards. It was included on Beall’s list, a discontinued compilation that identified publishers and journals alleged by its compiler to exhibit predatory or questionable practices. The available reference material does not record an official response from AME to its inclusion. Subsequently, one of the company’s journals published a commissioned editorial expressing skepticism about the list. Because inclusion on Beall’s list is an allegation or classification from an external source rather than a judicial finding, it should not by itself be treated as proof of misconduct. In 2020, AME signed up for Publons’ review-tracking service, a move described as intended to improve or document aspects of its peer-review processes. This placed the company within wider efforts to increase transparency around reviewer contributions and editorial workflows. The available sources do not provide detailed information about AME’s ownership, senior management, revenue, listing status, or current corporate structure. On the supplied evidence, it is best characterized as an active, privately held or otherwise unlisted academic publishing brand with a China- and Hong Kong-centered operating footprint and an international scholarly audience.

AME Publishing Company was founded in July 2009 as an academic publisher focused on medical communication. It established its headquarters in Hong Kong and developed an additional office network in mainland China and Taiwan, including locations in Guangzhou, Changsha, Nanjing, Shanghai, Chengdu, Beijing, Taipei, and Hangzhou. This geographic structure placed the company close to medical universities, hospitals, researchers, and professional communities in major East Asian research centers. The company’s publishing activity has centered on medical journals. Available descriptions report that AME has published more than 50 medical journals, with later descriptions referring to more than 60. The portfolio is complemented by books in both English and Chinese, as well as electronic books. Reported output includes more than 20 English-language books, 28 Chinese-language books, and 60 e-books. The sources do not provide enough information to reconstruct a complete chronology of individual journal launches, acquisitions, imprints, or changes in editorial leadership. AME’s name has been associated with several expansions of the acronym, including “Academic Made Easy,” “Academic Made Excellent,” and “Academic Made Enthusiastic.” These formulations reflect a publishing mission centered on facilitating the creation, review, and dissemination of academic and clinical knowledge. The publisher later became part of debates surrounding scholarly publishing quality and integrity after being included on Beall’s list. The list, maintained by librarian Jeffrey Beall until its discontinuation, identified publishers and journals that he considered predatory or potentially exploitative. The supplied reference states that AME did not issue an official response statement. It also states that one of AME’s journals subsequently published a commissioned editorial skeptical of Beall’s list. The episode is significant to the company’s public history because it connected AME to a broader controversy over peer review, open-access business models, journal standards, and the criteria used to evaluate emerging publishers. The available material does not establish that any court or regulator found AME liable for wrongdoing. In 2020, AME signed up to Publons’ review-tracking service. This was presented as an initiative to improve peer-review processes, or at least to make reviewer activity and editorial workflows more traceable. The development occurred amid a wider movement in academic publishing toward greater recognition of peer reviewers and more visible quality-control practices. The supplied sources do not identify AME’s founder, chief executives, owner, parent company, revenue, or listing status. They also do not provide a detailed account of current operations beyond the continuing publication of medical journals and books. On the available evidence, AME remains an active specialist academic publisher with a Hong Kong base, a broad Chinese office network, and an international readership and contributor community.

1. 2020Publons review-tracking registration

   AME signed up to Publons in an effort associated with improving and documenting its peer-review processes.

   Source
2. 2009AME Publishing Company founded

   AME Publishing Company was established in July 2009 as an academic publisher focused on medical journals and books.

   Source
3. Expansion of medical publishing program

   AME developed a publishing program reported to include more than 50 medical journals, later described as more than 60, together with English-language books, Chinese-language books, and e-books.

   Source

A specialist academic and medical publisher serving clinicians, researchers, medical institutions, and scholarly readers through journals, books, and digital publications.

• Medical journalsAcademic journals

  AME's core publishing product is a portfolio of medical journals. The available reference material describes more than 50 journals and, in a later account, more than 60. The portfolio serves clinical, biomedical, surgical, and related healthcare fields, although a complete list of titles and their individual specialties is not available in the supplied material.

• English-language medical booksAcademic books

  AME publishes medical books in English for an international scholarly and clinical audience. Reported output includes more than 20 English-language books. The available source does not identify the titles, authors, or subject areas of individual books.

• Chinese-language medical booksAcademic books

  The company also publishes medical books in Chinese, supporting researchers, clinicians, students, and professional readers in Chinese-speaking markets. The supplied material reports 28 Chinese-language books but does not provide a title-level catalogue.

• AME e-booksElectronic books

  AME's digital book output extends its medical publishing program beyond print. Reference material reports 60 e-books, though it does not specify whether this figure represents current availability, cumulative publications, or a particular catalogue snapshot.

• 2020Adoption of Publons review trackingStrategy

  AME faced the need to demonstrate or strengthen the transparency of its scholarly peer-review practices amid wider scrutiny of academic publishing standards.

  What changed. The company signed up to Publons, a service that tracks and recognizes peer-review activity.

  Aftermath. The registration was described as an effort to improve peer-review processes. The supplied material does not provide measurable results or subsequent changes to AME's editorial policies.

  Source

• Inclusion on Beall's listControversy

  AME Publishing Company was included on Beall's list, a controversial external list of publishers and journals alleged by its compiler to exhibit predatory or questionable practices. The available material says AME did not issue an official response. The listing is an allegation or classification by an external commentator and is not, on the supplied evidence, a judicial or regulatory determination.

  Source
• Editorial criticism of Beall's listControversy

  One of AME's journals later published a commissioned editorial skeptical of Beall's list. The supplied source does not identify the journal, author, or date of publication.

  Source

• 2020AME joins Publons review-tracking service

  AME Publishing Company signed up to Publons, a service for tracking and recognizing peer-review activity. The move was described as an effort to improve its peer-review processes and related transparency.

  Other
  Source

1. AME Publishing Company